This Week in CBD: November 16, 2018
A paper in this month’s edition of Forensic Science International took a close look at adulterated CBD e-liquid products.
The researchers analyzed samples of nine products from a single manufacturer, and while all of the products contained CBD, several also contained dangerous additives.
According to investigator Michelle Peace, the impetus for this research was the report from an individual who had experienced a surprising high after consuming Liquid Gold and Diamond CBD products.
Peace told VCU News, a platform associated with the Virginia Commonwealth University:
CBD is not supposed to make you high, but it has purported medical benefits. So when this person said they vaped this product and had a really awful high, we thought, “Wow, there is definitely something in there that shouldn’t be.”
Four products contained the synthetic cannabinoid 5F-ADB, and one contained dextromethorphan (DXM).
5F-ADB is a schedule 1 controlled substance. It has similar effects to THC, but according to the World Health Organization, it is much more likely to cause severe side effects. These can include loss of consciousness, cardiovascular effects, seizures, vomiting, psychosis, and aggressive behavior.
DXM, on the other hand, is a common ingredient in over-the-counter cough suppressants. At high doses it can cause euphoria, hallucinations, and “out-of-body” dissociative experiences.
The researchers concluded that their findings make clear the need for oversight of CBD products, saying:
The ﬁnding of both 5F-ADB and DXM were both unexpected.There was no indication on the website, box or labeled e-liquid containers to indicate that these products contained any psychoactive substance other than CBD. The analysis of these products illustrates the potential quality control issues that can occur in an unregulated industry. CBD products are believed by many users to offer health beneﬁts, but the detection of a dangerous cannabimimetic, 5F-ADB, and DXM in the analyzed products illustrates the need for oversight of CBD products.
The US Hemp Roundtable is urging people in Ohio, Alabama, and Michigan to contact their representatives about hemp-derived CBD products. Each state has legislation in progress that would clarify the legality of hemp CBD.
Ready to take action? Visit the Roundtable’s portal to send an email to your state legislators, and urge them to support this legislation.
One brewery’s CBD-infused beer is back in production after a long hiatus.
Aurora, Colorado-based Dad & Dude’s Breweria resumed production in July for the IPA they’ve named George Washington’s Secret Stash. The brewery got approval for the beer from the federal Alcohol and Tobacco Tax and Trade Bureau (TTB) back in 2016.
But after the DEA’s statements later that year, which asserted that CBD is a schedule 1 substance even if it’s derived from hemp, the TTB rescinded their approval.
Now, with the imminent passage of the 2018 Farm Bill, George Washington’s Secret Stash is poised to make a comeback.
Massachusetts Representative Seth Moulton and Representative Matt Gaetz of Florida have partnered to introduce new legislation this week that would make it easier for veterans to access medical cannabis.
According to the Boston Globe, “The proposal would require VA doctors to incorporate cannabis into veterans’ treatment plans and VA facilities to prominently post the policy.”
The bill’s supporters hope that cannabis will be integrated into treatment for PTSD and chronic pain.
Why are some parents saying no to Epidiolex for their children with epilepsy? The Burlington Free Press spoke to a mother who is sticking her current over-the-counter hemp-derived CBD brand for her daughter.
Is using cannabis the only way to support your endocannabinoid system (ECS)? Not by a long shot, according to Organic Authority. They suggest several diet and lifestyle changes that could help bring the ECS back into balance when things are out of whack.
Strainprint, a mobile app that helps medical cannabis consumers navigate the many available strain and dosage options, is launching an international clinical study to investigate the use of cannabis to treat endometriosis.
In partnership with Israeli researchers Lumir Lab and Gynica, Strainprint will conduct simultaneous studies in Israel and Canada. Their goal is to research the effects of cannabinoids on women’s health and gynecological disorders.
Exclusive CBD Deals
Pure Hemp Botanicals
Use the code cbdhack15 for 15% off all products.
And for a limited time, while supplies last each order will come with a scratch-off ticket with at least 15%-30% off your next purchase. One customer will receive a Grand Prize ticket valued at over $400!
Use the code 15CBDH for 15% off all products.
4 Corners Cannabis
Use the code 10CBDHacker for 10% off all products.
Use the code cbdhacker10 for 10% off all products.